Rhinology

Results: 169



#Item
21Microsoft Word - AwardWinnersCOSMFancyWithDistinction.docx

Microsoft Word - AwardWinnersCOSMFancyWithDistinction.docx

Add to Reading List

Source URL: www.triological.org

Language: English - Date: 2015-04-30 12:28:11
22REPORT BY THE COMMONWEALTH AND IMMIGRATION OMBUDSMAN FOR TABLING IN PARLIAMENT Under s 486O of the Migration Act 1958 This is the second s 486O report on Ms X. The first reportwas tabled in Parliament on 5 March

REPORT BY THE COMMONWEALTH AND IMMIGRATION OMBUDSMAN FOR TABLING IN PARLIAMENT Under s 486O of the Migration Act 1958 This is the second s 486O report on Ms X. The first reportwas tabled in Parliament on 5 March

Add to Reading List

Source URL: www.ombudsman.gov.au.

Language: English - Date: 2015-03-04 20:55:16
23UNIVERSITY OF KARACHI KARACHI (EXAMINATIONS DEPARTMENT) Candidates bearing the following seat numbers are hereby declared to have Passed Diploma in LARYNGOLOGY & OTO-RHINOLOGY (D.L.O) PART-I, Annual Examination 2010.

UNIVERSITY OF KARACHI KARACHI (EXAMINATIONS DEPARTMENT) Candidates bearing the following seat numbers are hereby declared to have Passed Diploma in LARYNGOLOGY & OTO-RHINOLOGY (D.L.O) PART-I, Annual Examination 2010.

Add to Reading List

Source URL: www.uok.edu.pk

Language: English - Date: 2015-01-27 08:36:02
24UNIVERSITY OF KARACHI KARACHI (EXAMINATIONS DEPARTMENT) Candidates bearing the following seat numbers are hereby declared to have Passed Diploma in LARYNGOLOGY & OTO-RHINOLOGY (D.L.O) PART-II, Annual Examination 2010.

UNIVERSITY OF KARACHI KARACHI (EXAMINATIONS DEPARTMENT) Candidates bearing the following seat numbers are hereby declared to have Passed Diploma in LARYNGOLOGY & OTO-RHINOLOGY (D.L.O) PART-II, Annual Examination 2010.

Add to Reading List

Source URL: www.uok.edu.pk

Language: English - Date: 2015-01-27 08:36:03
25Guidelines for General Practice  Management of Sinusitis Pre Referral Management Guidelines GP Management of SINUSITIS

Guidelines for General Practice Management of Sinusitis Pre Referral Management Guidelines GP Management of SINUSITIS

Add to Reading List

Source URL: www.nh.org.au

Language: English - Date: 2014-11-12 18:28:41
26Intersect ENT Announces Positive Data from Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Results Presented at the Annual American Rhinologic Society Meeting 2014; Recognized with Cottle Award fo

Intersect ENT Announces Positive Data from Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Results Presented at the Annual American Rhinologic Society Meeting 2014; Recognized with Cottle Award fo

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-09-22 08:56:58
27Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population PROGRESS Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Patients with

Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population PROGRESS Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Patients with

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-09-17 19:20:17
28Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery

Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-04-17 10:11:17
29Intersect ENT to Present at the 32nd Annual J.P. Morgan Healthcare Conference Menlo Park, Calif. – Jan. 8, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their

Intersect ENT to Present at the 32nd Annual J.P. Morgan Healthcare Conference Menlo Park, Calif. – Jan. 8, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-04-17 10:12:02
30Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate

Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-12-29 18:58:43